As expected, after knocking down FASRL expression with shRNA in the HepG2 and LM3 cell lines, the proliferation and migration of the HCC cells were significantly inhibited (Figure S11B–D, Supporting Information). Here, NQO1-DT is linked to hepatocellular carcinoma.